SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VOLINIA, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.320
AS - Asia 9.217
EU - Europa 5.286
SA - Sud America 1.625
AF - Africa 145
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 39.612
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.976
SG - Singapore 3.774
CN - Cina 2.594
BR - Brasile 1.375
UA - Ucraina 1.107
DE - Germania 1.049
HK - Hong Kong 952
TR - Turchia 814
IT - Italia 773
GB - Regno Unito 590
VN - Vietnam 502
FI - Finlandia 360
SE - Svezia 342
PL - Polonia 341
RU - Federazione Russa 321
MX - Messico 179
CA - Canada 135
ID - Indonesia 129
IN - India 113
AR - Argentina 104
FR - Francia 86
BD - Bangladesh 68
ZA - Sudafrica 64
ES - Italia 62
NL - Olanda 61
JP - Giappone 59
AT - Austria 50
BE - Belgio 42
EC - Ecuador 33
CO - Colombia 31
LT - Lituania 30
IQ - Iraq 29
IR - Iran 24
UZ - Uzbekistan 22
MA - Marocco 21
VE - Venezuela 19
CL - Cile 18
PK - Pakistan 18
CZ - Repubblica Ceca 17
UY - Uruguay 15
PY - Paraguay 14
AE - Emirati Arabi Uniti 13
IL - Israele 13
KR - Corea 12
EG - Egitto 11
SA - Arabia Saudita 11
PE - Perù 10
TN - Tunisia 10
AU - Australia 9
AZ - Azerbaigian 9
AL - Albania 8
JO - Giordania 8
KE - Kenya 8
RO - Romania 8
DZ - Algeria 7
NP - Nepal 7
BG - Bulgaria 6
ET - Etiopia 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
CH - Svizzera 5
GR - Grecia 5
CR - Costa Rica 4
GA - Gabon 4
JM - Giamaica 4
MY - Malesia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BH - Bahrain 3
DK - Danimarca 3
LB - Libano 3
MD - Moldavia 3
NI - Nicaragua 3
PA - Panama 3
RS - Serbia 3
SN - Senegal 3
TH - Thailandia 3
AM - Armenia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EU - Europa 2
GD - Grenada 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
MM - Myanmar 2
NG - Nigeria 2
OM - Oman 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SS - ???statistics.table.value.countryCode.SS??? 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BF - Burkina Faso 1
BO - Bolivia 1
Totale 39.585
Salva come PNG Salva come JPEG
Città #
Fairfield 3.009
Woodbridge 2.710
Singapore 2.145
Ashburn 2.056
Houston 1.602
Seattle 1.248
Jacksonville 1.240
Ann Arbor 1.190
Chandler 1.097
Wilmington 996
Cambridge 993
Hong Kong 946
Beijing 809
Santa Clara 800
Izmir 450
Dallas 402
Nanjing 355
Warsaw 326
Los Angeles 315
Princeton 285
Addison 248
San Diego 243
Ferrara 224
New York 220
Munich 202
Boardman 198
Ho Chi Minh City 175
Milan 146
São Paulo 132
Nanchang 119
Shanghai 118
Mexico City 105
Jakarta 98
Shenyang 93
Dearborn 91
Hanoi 89
London 85
Hebei 84
Hefei 80
Tianjin 79
Buffalo 77
Bremen 70
Turku 70
The Dalles 67
Denver 64
Falls Church 63
Mountain View 59
Jiaxing 57
San Mateo 57
Chicago 54
Helsinki 54
Jinan 52
Tokyo 52
Brooklyn 51
Stockholm 51
Changsha 50
Redwood City 47
Falkenstein 45
Rio de Janeiro 43
Johannesburg 42
Orem 42
Brussels 41
Toronto 41
Montreal 40
Moscow 40
Kunming 39
Columbus 38
Atlanta 37
Boston 37
Belo Horizonte 35
Chennai 34
Guangzhou 33
Nuremberg 33
Poplar 33
Amsterdam 31
Norwalk 31
San Francisco 31
Dong Ket 30
Frankfurt am Main 30
Ningbo 29
Phoenix 29
Orange 27
Des Moines 26
Manchester 26
Ankara 25
Mumbai 25
Ottawa 24
Porto Alegre 24
Vienna 24
Brasília 23
Tappahannock 23
Zhengzhou 23
Hangzhou 22
Taizhou 21
Auburn Hills 20
Bologna 20
Council Bluffs 20
Haiphong 19
Philadelphia 19
Tashkent 19
Totale 28.092
Salva come PNG Salva come JPEG
Nome #
Loss of miR-204 expression is a key event in melanoma 245
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 233
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 222
Correlation of expression between different IMAGE clones from the same UniGene cluster 218
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 214
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 214
MicroRNA Expression Signatures in Solid Malignancies 214
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 208
Identification of microRNA activity by Targets' Reverse EXpression. 207
Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples 205
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 203
Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset 201
Association between idiopathic hearing loss and mitochondrial DNA mutations: a study on 169 hearing-impaired subjects 197
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 197
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 196
A miRNA signature for defining aggressive phenotype and prognosis in gliomas 193
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 192
A microRNA signature for a BMP2-induced osteoblast lineage commitment program 192
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 192
Microevolution in Ferrara: Isonymy 1890–1990 191
Reprogramming of miRNA networks in cancer and leukemia 190
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 190
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 190
A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia 189
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation 188
GAMES identifies and annotates mutations in next-generation sequencing projects 187
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 184
Analysis of Differential Expression of TG2 Variants During Treatment with Retinoic Acid Highlights a New 3'-Terminal Transcript and Putatively Involved Proteins 184
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 183
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma 183
Inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations 182
MicroRNA expression profiling in human Barrett's carcinogenesis. 182
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 182
Analysis of osteoblast-like MG63 cells' response to a rough implant surface by means of DNA microarray 181
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 180
CG Dinucleotides of class II MHC genes are mutation hot-spots 176
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 175
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 173
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 170
Comparison of microRNA deep sequencing of matched formalin-fixed paraffin-embedded and fresh frozen cancer tissues. 169
Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma 169
Strong inverse correlation between MicroRNA-125b and human papillomavirus DNA in productive infection 169
GAS6 expression identifies high-risk adult AML patients: potential implications for therapy. 168
Espressione dei MicroRNA nei carcinomi mammari 165
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 164
The miR-1792 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes 163
RNA analysis indicates tight correlation between the expression of a long non coding RNA and the TG2 mRNA levels 163
Expression profiles of craniosynostosis-derived fibroblasts 162
Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts 162
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia 161
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 160
Partial gene deletion in a family with factor X deficiency 160
Involvement of non-coding RNAs and transcription factors in the induction of Transglutaminase isoforms by ATRA 160
A long non-coding RNA inside the type 2 transglutaminase gene tightly correlates with the expression of its transcriptional variants 160
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B 159
TOM: Transcriptomics of OMIM. 159
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 158
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway 157
Profiling of the Predicted Circular RNAs in Ductal In Situ and Invasive Breast Cancer: A Pilot Study 157
Metabolic Profiling of Breast Cancer Cell Lines: Unique and Shared Metabolites 156
CHARACTERIZATION OF THE PSEUDOGENIC REGION OF VON WILLEBRAND FACTOR BY MOLECULAR CLONING AND "IN SITU" HYBRIDIZATION 156
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model 155
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 155
Levels of miR-126 and miR-218 are elevated in ductal carcinoma in situ (DCIS) and inhibit malignant potential of DCIS derived cells 154
The role of microRNA genes in papillary thyroid carcinoma 153
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer 152
SNPs and somatic mutation on long non-coding RNA: New frontier in the cancer studies? 152
Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer 151
GOAL: automated gene ontology analisys of expression profiles. 150
A RECURRENT AMINOACID SUBSTITUTION AND A PARTIAL GENE DELETION IN SEVERE HEMOPHILIA A 148
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 148
MicroRNA profiles discriminate among colon cancer metastasis 148
SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome 147
null 146
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 146
Functional Implications of MicroRNAs in Acute Myeloid Leukemia by Integrating MicroRNA and Messenger RNA Expression Profiling 144
Suppression of MicroRNA-9 by Mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity 144
Mutational landscape and gene-expression patterns in adult acute myeloid leukemias with monosomy 7 as a sole abnormality 143
Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8 142
A Multidisciplinary Approach Establishes a Link between Transglutaminase 2 and the Kv10.1 Voltage-Dependent K+ Channel in Breast Cancer 141
The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism 141
miR-130A as a diagnostic marker to differentiate malignant mesothelioma from lung adenocarcinoma in pleural effusion cytology 141
Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression 141
Circulating tumor cells share RNA modules with early embryo trophectoderm and with metastatic cancer 141
MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis 140
null 139
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 137
Modulation of mismatch repair and genomic stability by miR-155 137
The network of non-coding RNAs in cancer drug resistance 136
The network of non-coding RNAs and their molecular targets in breast cancer 136
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 135
Dysregulation of Transglutaminase type 2 through GATA3 defines aggressiveness and Doxorubicin sensitivity in breast cancer 135
Unexpected findings of variability in microRNAs suggest roles in human genetics 134
Quaking and miR-155 interactions in inflammation and leukemogenesis 134
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells 133
null 132
UC.183, UC.110, and UC.84 ultra-conserved RNAs are mutually exclusive with mir-221 and are engaged in the cell cycle circuitry in breast cancer cell lines 132
RFLPs analysis in APCKD subjects from northern Italy 131
GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGFβ effectors, Drosha and microRNAs with opposite oncogenic potentials 130
ATRA modulates the expression of alternative Transglutaminase 2 in brain tumors through interactions between regulatory factors and intronic regions 130
Totale 16.694
Salva come PNG Salva come JPEG
Categoria #
all - tutte 173.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.065
Totale 176.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.408 0 0 0 0 0 456 155 510 100 484 479 224
2021/20223.197 174 363 351 56 137 117 155 116 93 243 293 1.099
2022/20232.647 275 114 90 300 443 409 115 247 367 26 166 95
2023/20241.240 155 203 61 38 74 177 63 61 31 25 51 301
2024/20255.665 155 154 476 211 697 441 186 393 931 626 768 627
2025/20268.929 1.506 749 1.585 2.156 2.337 596 0 0 0 0 0 0
Totale 40.016